Raiffeisen Bank International AG Purchases 12,228 Shares of Zoetis Inc. $ZTS

Raiffeisen Bank International AG lifted its position in shares of Zoetis Inc. (NYSE:ZTS) by 6.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 204,311 shares of the company’s stock after buying an additional 12,228 shares during the period. Raiffeisen Bank International AG’s holdings in Zoetis were worth $29,229,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Halbert Hargrove Global Advisors LLC boosted its holdings in Zoetis by 496.6% during the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock valued at $25,000 after acquiring an additional 144 shares during the period. NewSquare Capital LLC raised its holdings in Zoetis by 69.1% in the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after purchasing an additional 85 shares in the last quarter. Financial Consulate Inc. bought a new stake in shares of Zoetis during the 3rd quarter valued at $39,000. SJS Investment Consulting Inc. grew its holdings in Zoetis by 1,606.3% in the third quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock worth $40,000 after purchasing an additional 257 shares during the period. Finally, TruNorth Capital Management LLC bought a new position in shares of Zoetis during the third quarter valued at approximately $42,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Bank of America raised their price target on Zoetis from $135.00 to $140.00 and gave the company a “neutral” rating in a report on Friday, February 13th. Piper Sandler reissued a “neutral” rating and set a $135.00 price target (down previously from $190.00) on shares of Zoetis in a research report on Thursday, January 22nd. BTIG Research reaffirmed a “buy” rating and issued a $160.00 price objective on shares of Zoetis in a research report on Wednesday, December 3rd. The Goldman Sachs Group raised Zoetis to a “buy” rating in a report on Monday, December 15th. Finally, Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a research report on Saturday. Five investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $152.91.

Zoetis Stock Performance

ZTS stock opened at $128.73 on Friday. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $177.00. The company has a market cap of $54.34 billion, a P/E ratio of 21.38, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96. The stock’s fifty day moving average price is $125.41 and its 200-day moving average price is $134.80.

Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. The company had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.Zoetis’s revenue was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, equities analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 1.6%. Zoetis’s dividend payout ratio (DPR) is presently 35.22%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.